Qulipta Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Qulipta
M
- Margesic (acetaminophen / butalbital / caffeine)
- Marten-Tab (acetaminophen / butalbital)
- Matzim LA (diltiazem)
- mavacamten
- Mavyret (glecaprevir / pibrentasvir)
- Me-PB-Hyos (atropine / hyoscyamine / phenobarbital / scopolamine)
- Mebaral (mephobarbital)
- Medidex (dexamethasone)
- Medidex LA (dexamethasone)
- Medigesic (acetaminophen / butalbital / caffeine)
- mephobarbital
- metreleptin
- mibefradil
- Micomp-PB (belladonna / caffeine / ergotamine / pentobarbital)
- midostaurin
- Mifeprex (mifepristone)
- mifepristone
- Migracet-PB (belladonna / caffeine / ergotamine / pentobarbital)
- Minotal (acetaminophen / butalbital / caffeine)
- mitapivat
- mitotane
- mobocertinib
- modafinil
- Morning SickLess (ginger / magnesium sulfate / pyridoxine)
- Mudrane (aminophylline / ephedrine / phenobarbital / potassium iodide)
- Mudrane GG (aminophylline / ephedrine / guaifenesin / phenobarbital)
- Multaq (dronedarone)
- MY-E (erythromycin)
- Myalept (metreleptin)
- Mycapssa (octreotide)
- Mycelex Troche (clotrimazole)
- Mycobutin (rifabutin)
- Mygracet (acetaminophen / butalbital / caffeine)
- Mysoline (primidone)
More about Qulipta (atogepant)
- Qulipta consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (134)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.